Skip to main content

The Economics of Genomic Medicine Workshop Summary (2013) / Chapter Skim
Currently Skimming:

References
Pages 73-76

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 73...
... 2006. Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.
Read the entire page →
From page 74...
... 2001. Randomized phase III trial of paclitaxel plus carboplatin versus vinorel bine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial.
Read the entire page →
From page 75...
... 2003. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small-cell lung cancer: A randomized trial.
Read the entire page →
From page 76...
... Journal of the American Medical Association 287(2)
Read the entire page →

Key Terms

  • epidermal growth
  • blood type
  • factor receptor
  • family quartet
  • american journal

  • growth factor
  • genetic risk
  • birth weight
  • kinase inhibitors
  • myocardial infarction

  • association journal
  • maternal cigarette
  • cigarette smoking
  • sickle cell
  • novel targets

  • prothrombin mutations
  • clinical advances
  • clinical cancer
  • weight infants
  • abo blood

  • reduces hospitalization
  • genotyping reduces
  • low birth
  • iii trial
  • receptor tyrosine

  • common secondary
  • receptor gene
  • clinical trials
  • venous thromboembolism
  • metabolic gene


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.